Align Technology Inc (ALGN)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $11.70B
Last updated: Nov 17, 2026 at 4:20 PM ET
Align Technology Inc (ALGN) Statistics
Align Technology (ALGN) has a market cap of $11.70B and an enterprise value of $10.55B. Its trailing P/E of 15.9x is below its 10-year median of 42.8x.
Total Valuation
Enterprise value is 9.79% below the market cap, as cash exceeds debt.
| Market Cap | $11.70B |
|---|---|
| Enterprise Value | $10.55B |
| Latest price (Nov 17, 2026) | $163.46 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 28, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.8x and 2.7x. Its year-end P/E ranged from 14.8x to 102.0x from 2016 to 2025.
| P/E Ratio | 15.9x |
|---|---|
| Forward P/E | 14.5x |
| P/S Ratio | 2.8x |
| Forward P/S | 2.8x |
| P/B Ratio | 2.7x |
| P/TBV Ratio | 3.1x |
| P/FCF Ratio | 19.3x |
| P/OCF Ratio | 15.6x |
| PEG Ratio | 1.2 |
Enterprise Valuation
Counting debt and cash, the company is valued at 12.1x EBITDA and 17.4x free cash flow.
| EV / Earnings | 21.5x |
|---|---|
| EV / Sales | 2.5x |
| EV / EBITDA | 12.1x |
| EV / FCF | 17.4x |
Price Statistics
The stock is up 19.20% over 52 weeks and trades 7.53% above its 50-day average.
| Beta (1Y) | 1.30 |
|---|---|
| 52-Week Change | +19.20% |
| 1-Month Change | +9.70% |
| 3-Month Change | +0.26% |
| 6-Month Change | +5.35% |
| 5-Year Change | -75.99% |
| 10-Year Change | +74.45% |
| Total Return (1Y) | +19.20% |
| Total Return (3Y CAGR) | -7.51% |
| Total Return (5Y CAGR) | -24.91% |
| Return vs SPY (1Y) | +12.01% |
| Max Drawdown (1Y) | -29.18% |
| Max Drawdown (3Y) | -62.19% |
| Sharpe Ratio (1Y) | 0.53 |
| Correlation with SPY (1Y) | 0.45 |
| 50-Day Average | $152.02 |
| 200-Day Average | $168.69 |
| 52-Week Range | $131.95 to $200.44 |
| RSI (14 Days) | 54.9 |
| Average Volume (20 Days) | 1.20M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.42x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.42x |
|---|---|
| Quick Ratio | 1.31x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 11.42% over the last 12 months, against a 5-year average of 12.94%.
| Return on Equity (ROE) | 11.42% |
|---|---|
| Return on Assets (ROA) | 7.54% |
| ROE (5Y Average) | 12.94% |
| ROA (5Y Average) | 7.95% |
| ROIC (5Y Average) | 12.45% |
| Asset Turnover | 0.65x |
| Inventory Turnover | 5.88x |
| Receivables Turnover | 3.60x |
| Cash Conversion Cycle | 131 days |
Taxes
Income tax took 23.65% of pretax income over the last 12 months.
| Income Tax (TTM) | $152.38M |
|---|---|
| Effective Tax Rate | 23.65% |
Scores
ALGN has an Altman Z-Score of 4.81, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.81 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $4.16B over the last 12 months is up 4.42% from the 12 months before.
| Revenue | $4.16B |
|---|---|
| Revenue Growth (YoY) | +4.42% |
| Gross Profit | $2.88B |
| Operating Income | $620.46M |
| Pretax Income | $644.25M |
| Net Income | $491.87M |
| EBITDA | $862.99M |
| Reported EPS (TTM) | $10.29 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 66.10% of the $6.52B in total assets.
| Cash and Equivalents | $1.14B |
|---|---|
| Total Debt | $0 |
| Net Cash | $1.14B |
| Net Cash Per Share | $16.13 |
| Working Capital | $812.58M |
| Shareholder Equity | $4.31B |
| Book Value Per Share | $60.65 |
| Tangible Book Value | $3.72B |
| Tangible Book Per Share | $52.39 |
| Total Assets | $6.52B |
| Total Liabilities | $2.22B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $147.39M of capital spending, operating cash flow left $602.50M of free cash flow.
| Operating Cash Flow | $749.89M |
|---|---|
| Capital Expenditures | $147.39M |
| Free Cash Flow | $602.50M |
| FCF Per Share | $8.48 |
| Depreciation and Amortization | $238.12M |
| Share Repurchases | $298.44M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 14.92%, against a 5-year average of 17.46%.
| Gross Margin | 69.14% |
|---|---|
| Operating Margin | 14.92% |
| Pretax Margin | 15.49% |
| Net Margin | 11.83% |
| EBITDA Margin | 20.75% |
| FCF Margin | 14.49% |
| Gross Margin (5Y Average) | 70.41% |
| Operating Margin (5Y Average) | 17.46% |
| Net Margin (5Y Average) | 12.29% |
Growth
Revenue grew 2.61% a year over 3 years, and EPS 13.37% a year.
| Revenue Growth (3Y CAGR) | +2.61% |
|---|---|
| Revenue Growth (5Y CAGR) | +10.30% |
| EPS Growth (3Y CAGR) | +13.37% |
| EPS Growth (5Y CAGR) | +14.96% |
| FCF Growth (3Y CAGR) | +21.03% |
| FCF Growth (5Y CAGR) | -0.66% |
| Operating Income Growth (3Y CAGR) | -5.30% |
| Book Value Per Share Growth (2Y CAGR) | +8.54% |
| Tangible Book Per Share Growth (2Y CAGR) | +8.14% |
Dividends and Yields
ALGN does not pay a dividend. Its free cash flow yield is 5.19%.
| Earnings Yield | 6.29% |
|---|---|
| FCF Yield | 5.19% |
| Buyback Yield | 2.40% |
| Shareholder Yield | 2.40% |
Peer Position
Against 11 similar companies, ALGN has the 9th highest P/E and the 7th highest P/S.
P/E RatioPeer median 20.7x
P/S RatioPeer median 2.9x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.01%
| P/E Ratio | 15.9x vs 20.7x median |
|---|---|
| P/S Ratio | 2.8x vs 2.9x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +4.42% vs +9.01% median |
Analyst Forecast
Consensus estimates put revenue growth at 2.55% and EPS growth at 8.08% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2.55% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +8.08% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ALGN
What is ALGN's market cap?
Align Technology has a market cap of $11.70B. Its enterprise value, which adds debt and subtracts cash, is $10.55B.
What is ALGN's P/E ratio?
Align Technology has a trailing P/E ratio of 15.9x and a forward P/E of 14.5x.
How many shares of ALGN are outstanding?
Align Technology has 70.99M shares outstanding. The count is down 1.91% from a year earlier.
Does ALGN pay a dividend?
No. Align Technology does not pay a dividend.
How much debt does ALGN have?
Align Technology has $0 of total debt and $1.14B of cash and equivalents, a net cash position of $1.14B.
ALGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors